201 related articles for article (PubMed ID: 36699068)
1. Study on the mechanism of action of
Yang AY; Liu HL; Yang YF
Front Pharmacol; 2022; 13():1072547. PubMed ID: 36699068
[No Abstract] [Full Text] [Related]
2. Molecular Assessment of
Shi H; Liu J; Fan J; He L; Wang X; Tang F; Tian D; He Y
Evid Based Complement Alternat Med; 2022; 2022():1988378. PubMed ID: 35178099
[TBL] [Abstract][Full Text] [Related]
3. AURKB, CHEK1 and NEK2 as the Potential Target Proteins of
Huang C; Luo H; Huang Y; Fang C; Zhao L; Li P; Zhong C; Liu F
Int J Gen Med; 2021; 14():3295-3312. PubMed ID: 34285555
[TBL] [Abstract][Full Text] [Related]
4. Exploration of the effect and mechanism of Scutellaria barbata D. Don in the treatment of ovarian cancer based on network pharmacology and in vitro experimental verification.
Zhang J; Qi C; Li H; Ding C; Wang L; Wu H; Dai W; Wang C
Medicine (Baltimore); 2023 Dec; 102(51):e36656. PubMed ID: 38134066
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of "Scutellaria barbata-Hedyotis diffusa" against breast cancer based on network pharmacology].
Jing XU; Feng-Qin S; Ke-Xin DU; Jia D; Dong-Yun LI
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4448-4454. PubMed ID: 33164375
[TBL] [Abstract][Full Text] [Related]
6. Network-based pharmacology-based research on the effect and mechanism of the Hedyotis diffusa-Scutellaria Barbata pair in the treatment of hepatocellular carcinoma.
Hou C; Wen X; Yan S; Gu X; Jiang Y; Chen F; Liu Y; Zhu Y; Liu X
Sci Rep; 2024 Jan; 14(1):963. PubMed ID: 38200019
[TBL] [Abstract][Full Text] [Related]
7. A network pharmacology and bioinformatics exploration of the possible molecular mechanisms of Fuzheng Xiaoliu Granule for the treatment of hepatocellular carcinoma.
Fan T; Chen X; Yang F; Li Y; Gao Q; Li S; Chen X; Chen X
J Clin Transl Res; 2023 Jun; 9(3):182-194. PubMed ID: 37275579
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology-based strategy to investigate the active ingredients and molecular mechanisms of Scutellaria Barbata D. Don against radiation pneumonitis.
Sun PY; Wang AS; Zhang ZF; Zhang YL; Zheng X
Medicine (Baltimore); 2021 Nov; 100(47):e27957. PubMed ID: 34964782
[TBL] [Abstract][Full Text] [Related]
9. Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway.
Xu X; Chen F; Zhang L; Liu L; Zhang C; Zhang Z; Li W
J Ethnopharmacol; 2021 Oct; 279():114343. PubMed ID: 34147618
[TBL] [Abstract][Full Text] [Related]
10. Molecular Targets and Mechanisms of
Yang Z; Lu S; Tang H; Qu J; Wang B; Wang Y; Pan G; Rao B
Evid Based Complement Alternat Med; 2022; 2022():6186662. PubMed ID: 35707465
[No Abstract] [Full Text] [Related]
11. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
12. Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma.
Li X; Zhou M; Chen W; Sun J; Zhao Y; Wang G; Wang B; Pan Y; Zhang J; Xu J
BMC Complement Med Ther; 2024 May; 24(1):208. PubMed ID: 38816744
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Therapeutic Mechanism of Hedyotis Diffusa Willd (HDW)‒ Scutellaria Barbata (SB) in Clear Cell Renal Cell Carcinoma
Bai Y; Chen R; Sun J; Guo Y
Comb Chem High Throughput Screen; 2024; 27(6):910-921. PubMed ID: 37526191
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technology.
Yang M; Yan Q; Luo Y; Wang B; Deng S; Luo H; Ye B; Wang X
Front Pharmacol; 2023; 14():1016967. PubMed ID: 36744264
[No Abstract] [Full Text] [Related]
15. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
[TBL] [Abstract][Full Text] [Related]
16.
Cai X; Peng S; Wang L; Tang D; Zhang P
Evid Based Complement Alternat Med; 2023; 2023():4572660. PubMed ID: 36874613
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the pharmacological mechanisms of Scutellaria baicalensis Georgi on oral leukoplakia by combining network pharmacology, molecular docking and experimental evaluations.
Hou F; Yu Z; Cheng Y; Liu Y; Liang S; Zhang F
Phytomedicine; 2022 Aug; 103():154195. PubMed ID: 35667260
[TBL] [Abstract][Full Text] [Related]
18. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
19. Network Pharmacology Analysis and In Vitro Validation of the Active Ingredients and Potential Mechanisms of Gynostemma Pentaphyllum Against Esophageal Cancer.
Guo J; Wu Z; Chang X; Huang M; Wang Y; Liu R; Li J
Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38243957
[TBL] [Abstract][Full Text] [Related]
20. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
